These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 33753200
1. A novel nuclear localization region in SIPA1 determines protein nuclear distribution and epirubicin-sensitivity of breast cancer cells. Ma Y, Weng J, Wang N, Zhang Y, Minato N, Su L. Int J Biol Macromol; 2021 Jun 01; 180():718-728. PubMed ID: 33753200 [Abstract] [Full Text] [Related]
2. Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells. Zhang Y, Gong Y, Hu D, Zhu P, Wang N, Zhang Q, Wang M, Aldeewan A, Xia H, Qu X, Ring BZ, Minato N, Su L. Oncogene; 2015 Mar 12; 34(11):1451-62. PubMed ID: 24704834 [Abstract] [Full Text] [Related]
3. A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer. Guo L, Zhang W, Zhang X, Wang J, Nie J, Jin X, Ma Y, Wang S, Zhou X, Zhang Y, Xu Y, Tanaka Y, Yuan J, Liao XH, Gong Y, Su L. Oncogene; 2023 Aug 12; 42(35):2641-2654. PubMed ID: 37500797 [Abstract] [Full Text] [Related]
4. SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells. Wang N, Weng J, Xia J, Zhu Y, Chen Q, Hu D, Zhang X, Sun R, Feng J, Minato N, Gong Y, Su L. Stem Cell Res; 2020 Dec 12; 49():102099. PubMed ID: 33296812 [Abstract] [Full Text] [Related]
5. SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7. Takahara T, Kasamatsu A, Yamatoji M, Iyoda M, Kasama H, Saito T, Takeuchi S, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K. Exp Cell Res; 2017 Mar 15; 352(2):357-363. PubMed ID: 28237246 [Abstract] [Full Text] [Related]
8. The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients. Ugenskienė R, Myrzaliyeva D, Jankauskaitė R, Gedminaitė J, Jančiauskienė R, Šepetauskienė E, Juozaitytė E. Biomarkers; 2016 Mar 15; 21(4):363-70. PubMed ID: 26901824 [Abstract] [Full Text] [Related]
9. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel. Wang C, Pan YH, Shan M, Xu M, Bao JL, Zhao LM. Int J Mol Sci; 2015 Mar 02; 16(3):4698-712. PubMed ID: 25739083 [Abstract] [Full Text] [Related]
17. The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies. Yi SM, Li GY. Tumour Biol; 2014 Jan 02; 35(1):441-5. PubMed ID: 24006220 [Abstract] [Full Text] [Related]
18. SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Khongkow M, Olmos Y, Gong C, Gomes AR, Monteiro LJ, Yagüe E, Cavaco TB, Khongkow P, Man EP, Laohasinnarong S, Koo CY, Harada-Shoji N, Tsang JW, Coombes RC, Schwer B, Khoo US, Lam EW. Carcinogenesis; 2013 Jul 02; 34(7):1476-86. PubMed ID: 23514751 [Abstract] [Full Text] [Related]
19. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M. Int J Cancer; 2009 Apr 01; 124(7):1716-20. PubMed ID: 19089925 [Abstract] [Full Text] [Related]
20. Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via ATG12. Sun WL, Wang L, Luo J, Zhu HW, Cai ZW. Cancer Sci; 2018 Oct 01; 109(10):3129-3138. PubMed ID: 30027574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]